Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 46

1.

Temporal trends in the accuracy of hospital diagnostic coding for identifying acute stroke: A population-based study.

Li L, Binney LE, Luengo-Fernandez R, Silver LE, Rothwell PM; Oxford Vascular Study.

Eur Stroke J. 2020 Mar;5(1):26-35. doi: 10.1177/2396987319881017. Epub 2019 Oct 14.

2.

Economic burden of stroke across Europe: A population-based cost analysis.

Luengo-Fernandez R, Violato M, Candio P, Leal J.

Eur Stroke J. 2020 Mar;5(1):17-25. doi: 10.1177/2396987319883160. Epub 2019 Oct 29.

3.

Ten-year risks of recurrent stroke, disability, dementia and cost in relation to site of primary intracerebral haemorrhage: population-based study.

Li L, Luengo-Fernandez R, Zuurbier SM, Beddows NC, Lavallee P, Silver LE, Kuker W, Rothwell PM.

J Neurol Neurosurg Psychiatry. 2020 Mar 12. pii: jnnp-2019-322663. doi: 10.1136/jnnp-2019-322663. [Epub ahead of print]

4.

Effect of Thoracoscopic Talc Poudrage vs Talc Slurry via Chest Tube on Pleurodesis Failure Rate Among Patients With Malignant Pleural Effusions: A Randomized Clinical Trial.

Bhatnagar R, Piotrowska HEG, Laskawiec-Szkonter M, Kahan BC, Luengo-Fernandez R, Pepperell JCT, Evison MD, Holme J, Al-Aloul M, Psallidas I, Lim WS, Blyth KG, Roberts ME, Cox G, Downer NJ, Herre J, Sivasothy P, Menzies D, Munavvar M, Kyi MM, Ahmed L, West AG, Harrison RN, Prudon B, Hettiarachchi G, Chakrabarti B, Kavidasan A, Sutton BP, Zahan-Evans NJ, Quaddy JL, Edey AJ, Clive AO, Walker SP, Little MHR, Mei XW, Harvey JE, Hooper CE, Davies HE, Slade M, Sivier M, Miller RF, Rahman NM, Maskell NA.

JAMA. 2019 Dec 5. doi: 10.1001/jama.2019.19997. [Epub ahead of print]

PMID:
31804680
5.

The Osteoarthritis Thumb Therapy (OTTER) II Trial: a study protocol for a three-arm multi-centre randomised placebo controlled trial of the clinical effectiveness and efficacy and cost-effectiveness of splints for symptomatic thumb base osteoarthritis.

Adams J, Barratt P, Arden NK, Barbosa Bouças S, Bradley S, Doherty M, Dutton S, Dziedzic K, Gooberman-Hill R, Hislop Lennie K, Hutt Greenyer C, Jansen V, Luengo-Fernandez R, Meagher C, White P, Williams M.

BMJ Open. 2019 Oct 22;9(10):e028342. doi: 10.1136/bmjopen-2018-028342.

6.

Author response: Ordinal vs dichotomous analyses of modified Rankin Scale, 5-year outcome, and cost of stroke.

Ganesh A, Luengo-Fernandez R, Rothwell PM.

Neurology. 2019 Oct 15;93(16):725. doi: 10.1212/WNL.0000000000008328. No abstract available.

PMID:
31611320
7.

Costs of bleeding on long-term antiplatelet treatment without routine co-prescription of proton-pump inhibitors.

Luengo-Fernandez R, Li L, Rothwell PM; Oxford Vascular Study.

Int J Stroke. 2019 Sep 30:1747493019879658. doi: 10.1177/1747493019879658. [Epub ahead of print]

PMID:
31564244
8.

Nocturnal temperature-controlled laminar airflow device for adults with severe allergic asthma: the LASER RCT.

Kapoor M, Storrar W, Balls L, Brown TP, Mansur A, Hedley E, Jones T, Roberts C, Shirkey B, Dutton S, Luengo-Fernandez R, Little M, Dewey A, Marshall S, Fogg C, Boughton K, Rahman N, Yu LM, Bradding P, Howarth P, Chauhan AJ.

Health Technol Assess. 2019 Jun;23(29):1-140. doi: 10.3310/hta23290.

9.

Cost-effectiveness of intrapleural use of tissue plasminogen activator and DNase in pleural infection: evidence from the MIST2 randomised controlled trial.

Luengo-Fernandez R, Penz E, Dobson M, Psallidas I, Nunn AJ, Maskell NA, Rahman NM.

Eur Respir J. 2019 Aug 1;54(2). pii: 1801550. doi: 10.1183/13993003.01550-2018. Print 2019 Aug.

PMID:
31097519
10.

Cost-effectiveness of digital surveillance clinics with optical coherence tomography versus hospital eye service follow-up for patients with screen-positive maculopathy.

Leal J, Luengo-Fernandez R, Stratton IM, Dale A, Ivanova K, Scanlon PH.

Eye (Lond). 2019 Apr;33(4):640-647. doi: 10.1038/s41433-018-0297-7. Epub 2018 Nov 30.

11.

Long-Term Consequences of Worsened Poststroke Status in Patients With Premorbid Disability.

Ganesh A, Luengo-Fernandez R, Pendlebury ST, Rothwell PM.

Stroke. 2018 Oct;49(10):2430-2436. doi: 10.1161/STROKEAHA.118.022416.

12.

Ordinal vs dichotomous analyses of modified Rankin Scale, 5-year outcome, and cost of stroke.

Ganesh A, Luengo-Fernandez R, Wharton RM, Rothwell PM; Oxford Vascular Study.

Neurology. 2018 Nov 20;91(21):e1951-e1960. doi: 10.1212/WNL.0000000000006554. Epub 2018 Oct 19.

13.

Cost-effectiveness of cognitive-behavioural therapy for sleep disorder added to usual care in patients with schizophrenia: the BEST study.

Tsiachristas A, Waite F, Freeman D, Luengo-Fernandez R.

BJPsych Open. 2018 Apr 19;4(3):126-135. doi: 10.1192/bjo.2018.2. eCollection 2018 May.

14.

Hospital and Institutionalisation Care Costs after Limb and Visceral Ischaemia Benchmarked Against Stroke: Long-Term Results of a Population Based Cohort Study.

Luengo-Fernandez R, Howard DPJ, Nichol KG, Dobell E, Rothwell PM; Oxford Vascular Study.

Eur J Vasc Endovasc Surg. 2018 Aug;56(2):271-281. doi: 10.1016/j.ejvs.2018.03.007. Epub 2018 Apr 11.

15.

Time Course of Evolution of Disability and Cause-Specific Mortality After Ischemic Stroke: Implications for Trial Design.

Ganesh A, Luengo-Fernandez R, Wharton RM, Gutnikov SA, Silver LE, Mehta Z, Rothwell PM; Oxford Vascular Study.

J Am Heart Assoc. 2017 Jun 11;6(6). pii: e005788. doi: 10.1161/JAHA.117.005788.

16.

Cost-effectiveness of indwelling pleural catheter compared with talc in malignant pleural effusion.

Olfert JA, Penz ED, Manns BJ, Mishra EK, Davies HE, Miller RF, Luengo-Fernandez R, Gao S, Rahman NM.

Respirology. 2017 May;22(4):764-770. doi: 10.1111/resp.12962. Epub 2016 Dec 16.

PMID:
27983774
17.

Economic burden of non-malignant blood disorders across Europe: a population-based cost study.

Luengo-Fernandez R, Burns R, Leal J.

Lancet Haematol. 2016 Aug;3(8):e371-8. doi: 10.1016/S2352-3026(16)30061-8. Epub 2016 Jul 22.

PMID:
27476788
18.

Economic burden of malignant blood disorders across Europe: a population-based cost analysis.

Burns R, Leal J, Sullivan R, Luengo-Fernandez R.

Lancet Haematol. 2016 Aug;3(8):e362-70. doi: 10.1016/S2352-3026(16)30062-X. Epub 2016 Jul 22.

PMID:
27476787
19.

Cost-utility analysis of stenting versus endarterectomy in the International Carotid Stenting Study.

Morris S, Patel NV, Dobson J, Featherstone RL, Richards T, Luengo-Fernandez R, Rothwell PM, Brown MM; International Carotid Stenting Study investigators.

Int J Stroke. 2016 Jun;11(4):446-53. doi: 10.1177/1747493016632237. Epub 2016 Feb 15.

20.

Temperature-controlled laminar airflow in severe asthma for exacerbation reduction (The LASER Trial): study protocol for a randomised controlled trial.

Storrar W, Fogg C, Brown T, Dennison P, Yu LM, Dewey A, Luengo-Fernandez R, Dean T, Rahman N, Mansur A, Howarth PH, Bradding P, Chauhan AJ.

Trials. 2016 Jan 8;17:15. doi: 10.1186/s13063-015-1134-y.

21.

Economic Burden of Bladder Cancer Across the European Union.

Leal J, Luengo-Fernandez R, Sullivan R, Witjes JA.

Eur Urol. 2016 Mar;69(3):438-47. doi: 10.1016/j.eururo.2015.10.024. Epub 2015 Oct 25.

22.

Development of a cost-effectiveness model for optimisation of the screening interval in diabetic retinopathy screening.

Scanlon PH, Aldington SJ, Leal J, Luengo-Fernandez R, Oke J, Sivaprasad S, Gazis A, Stratton IM.

Health Technol Assess. 2015 Sep;19(74):1-116. doi: 10.3310/hta19740.

23.

Efficacy of cognitive behavioural therapy for sleep improvement in patients with persistent delusions and hallucinations (BEST): a prospective, assessor-blind, randomised controlled pilot trial.

Freeman D, Waite F, Startup H, Myers E, Lister R, McInerney J, Harvey AG, Geddes J, Zaiwalla Z, Luengo-Fernandez R, Foster R, Clifton L, Yu LM.

Lancet Psychiatry. 2015 Nov;2(11):975-83. doi: 10.1016/S2215-0366(15)00314-4. Epub 2015 Sep 9.

24.

UK research spend in 2008 and 2012: comparing stroke, cancer, coronary heart disease and dementia.

Luengo-Fernandez R, Leal J, Gray A.

BMJ Open. 2015 Apr 13;5(4):e006648. doi: 10.1136/bmjopen-2014-006648.

25.

Age-specific incidence, outcome, cost, and projected future burden of atrial fibrillation-related embolic vascular events: a population-based study.

Yiin GS, Howard DP, Paul NL, Li L, Luengo-Fernandez R, Bull LM, Welch SJ, Gutnikov SA, Mehta Z, Rothwell PM; Oxford Vascular Study.

Circulation. 2014 Oct 7;130(15):1236-44. doi: 10.1161/CIRCULATIONAHA.114.010942. Epub 2014 Sep 10.

26.

Economic burden of cancer across the European Union: a population-based cost analysis.

Luengo-Fernandez R, Leal J, Gray A, Sullivan R.

Lancet Oncol. 2013 Nov;14(12):1165-74. doi: 10.1016/S1470-2045(13)70442-X. Epub 2013 Oct 14.

PMID:
24131614
27.

Quality of life after TIA and stroke: ten-year results of the Oxford Vascular Study.

Luengo-Fernandez R, Gray AM, Bull L, Welch S, Cuthbertson F, Rothwell PM; Oxford Vascular Study.

Neurology. 2013 Oct 29;81(18):1588-95. doi: 10.1212/WNL.0b013e3182a9f45f. Epub 2013 Oct 9.

28.

Population-based study of disability and institutionalization after transient ischemic attack and stroke: 10-year results of the Oxford Vascular Study.

Luengo-Fernandez R, Paul NL, Gray AM, Pendlebury ST, Bull LM, Welch SJ, Cuthbertson FC, Rothwell PM; Oxford Vascular Study.

Stroke. 2013 Oct;44(10):2854-61. doi: 10.1161/STROKEAHA.113.001584. Epub 2013 Aug 6.

29.

The effects of using cognitive behavioural therapy to improve sleep for patients with delusions and hallucinations (the BEST study): study protocol for a randomized controlled trial.

Freeman D, Startup H, Myers E, Harvey A, Geddes J, Yu LM, Zaiwalla Z, Luengo-Fernandez R, Foster R, Lister R.

Trials. 2013 Jul 11;14:214. doi: 10.1186/1745-6215-14-214.

30.

Hospitalization resource use and costs before and after TIA and stroke: results from a population-based cohort study (OXVASC).

Luengo-Fernandez R, Silver LE, Gutnikov SA, Gray AM, Rothwell PM.

Value Health. 2013 Mar-Apr;16(2):280-7. doi: 10.1016/j.jval.2012.10.013. Epub 2013 Jan 11.

31.

Feasibility, safety and cost of outpatient management of acute minor ischaemic stroke: a population-based study.

Paul NL, Koton S, Simoni M, Geraghty OC, Luengo-Fernandez R, Rothwell PM.

J Neurol Neurosurg Psychiatry. 2013 Mar;84(3):356-61. doi: 10.1136/jnnp-2012-303585. Epub 2012 Nov 20.

32.

A population-based study of hospital care costs during 5 years after transient ischemic attack and stroke.

Luengo-Fernandez R, Gray AM, Rothwell PM; Oxford Vascular Study.

Stroke. 2012 Dec;43(12):3343-51. doi: 10.1161/STROKEAHA.112.667204. Epub 2012 Nov 15.

33.

Population-based study of acute- and long-term care costs after stroke in patients with AF.

Luengo-Fernandez R, Yiin GS, Gray AM, Rothwell PM.

Int J Stroke. 2013 Jul;8(5):308-14. doi: 10.1111/j.1747-4949.2012.00812.x. Epub 2012 May 9.

34.

UK research expenditure on dementia, heart disease, stroke and cancer: are levels of spending related to disease burden?

Luengo-Fernandez R, Leal J, Gray AM.

Eur J Neurol. 2012 Jan;19(1):149-54. doi: 10.1111/j.1468-1331.2011.03500.x. Epub 2011 Sep 24.

PMID:
21951976
35.

Cost of dementia in the pre-enlargement countries of the European Union.

Luengo-Fernandez R, Leal J, Gray AM.

J Alzheimers Dis. 2011;27(1):187-96. doi: 10.3233/JAD-2011-102019.

PMID:
21860095
36.

[Economic evaluation of healthcare technologies: an introduction for physicians].

Luengo-Fernández R, Hernández-Quesada C, Rivero-Arias O.

Rev Neurol. 2011 Jul 16;53(2):107-15. Review. Spanish.

37.

Independent validation of the prolonged length of stay score.

Koton S, Luengo-Fernandez R, Mehta Z, Rothwell PM.

Neuroepidemiology. 2010;35(4):263-6. doi: 10.1159/000320241. Epub 2010 Sep 24.

PMID:
20881429
38.

ABCD2 score predicts severity rather than risk of early recurrent events after transient ischemic attack.

Chandratheva A, Geraghty OC, Luengo-Fernandez R, Rothwell PM; Oxford Vascular Study.

Stroke. 2010 May;41(5):851-6. doi: 10.1161/STROKEAHA.109.570010. Epub 2010 Mar 18.

PMID:
20299668
39.

Mapping the modified Rankin scale (mRS) measurement into the generic EuroQol (EQ-5D) health outcome.

Rivero-Arias O, Ouellet M, Gray A, Wolstenholme J, Rothwell PM, Luengo-Fernandez R.

Med Decis Making. 2010 May-Jun;30(3):341-54. doi: 10.1177/0272989X09349961. Epub 2009 Oct 26.

PMID:
19858500
40.

Effect of urgent treatment for transient ischaemic attack and minor stroke on disability and hospital costs (EXPRESS study): a prospective population-based sequential comparison.

Luengo-Fernandez R, Gray AM, Rothwell PM.

Lancet Neurol. 2009 Mar;8(3):235-43. doi: 10.1016/S1474-4422(09)70019-5. Epub 2009 Feb 4.

41.

Costs of stroke using patient-level data: a critical review of the literature.

Luengo-Fernandez R, Gray AM, Rothwell PM.

Stroke. 2009 Feb;40(2):e18-23. doi: 10.1161/STROKEAHA.108.529776. Epub 2008 Dec 24. Review.

PMID:
19109540
42.

Population-based study of determinants of initial secondary care costs of acute stroke in the United Kingdom.

Luengo-Fernandez R, Gray AM, Rothwell PM.

Stroke. 2006 Oct;37(10):2579-87. Epub 2006 Aug 31.

PMID:
16946157
43.

Economic evaluation. Part 2: frameworks for combining costs and benefits in health care.

McIntosh E, Luengo-Fernandez R.

J Fam Plann Reprod Health Care. 2006 Jul;32(3):176-80. No abstract available.

44.

Economic evaluation. Part 1: Introduction to the concepts of economic evaluation in health care.

McIntosh E, Luengo-Fernandez R.

J Fam Plann Reprod Health Care. 2006 Apr;32(2):107-12. No abstract available. Erratum in: J Fam Plann Reprod Health Care. 2006 Jul;32(3):175.

45.

Cost of cardiovascular diseases in the United Kingdom.

Luengo-Fernández R, Leal J, Gray A, Petersen S, Rayner M.

Heart. 2006 Oct;92(10):1384-9. Epub 2006 May 15.

46.

Economic burden of cardiovascular diseases in the enlarged European Union.

Leal J, Luengo-Fernández R, Gray A, Petersen S, Rayner M.

Eur Heart J. 2006 Jul;27(13):1610-9. Epub 2006 Feb 22.

PMID:
16495286

Supplemental Content

Loading ...
Support Center